Logo
DCA

Becton, Dickinson and Company

sp500
BDXHealthcareMedical Instruments & Supplies
158,17 $US
-1.10%
Letzter Preis
158,17 $US
2026-07-17
24h Änderung
-1.10%
-1.76 USD
Volumen
1,7 Mio.
Gehandelte Anteile
Datenzuverlässigkeit
Hoch
13464 Punkte (53 Jahre)

Kursentwicklung

Starten Sie eine Simulation mit diesem Asset

BDX

Globale Parameter

Verfügbare Daten von 21.2.1973 bis 17.7.2026

Fundamentalanalyse

New
CAGR (5y)
4.99%
Revenue Growth
Net Margin
7.68%
Profitability
ROE
6.61%
Return on Equity
Debt / EBITDA
3.87
Solvency
PEG Ratio
1.11
Valuation vs Growth
Rev. Growth (TTM)
5.20%
Current Trend

KGV-Historie (5 Jahre)

Historical PE
Average (39.5x)
Current: 27.6x
Technischer Fokus
BDX
30d-Volatilität
26.05%
Abstand zur MA50
6.20%
Abstand zur MA200
-8.81%
Abstand zum ATH
-44.23%
Momentum 3M
-0.23%
Risiko-Score
N/A

Moderate Volatilität. Momentum neutral.

Über Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

In diesen Wert investieren
Kaufen bei Saxo Bank
🏦Regulierter Broker
🌍Globaler Marktzugang
📈Profi-Tools

Werbelink. Kapital unterliegt Risiken.

Technische Analyse & Risiko

Schlüsselkennzahlen

CAGR8.27%
Volatilität26.05%
Max Drawdown-50.38%

Momentum : BDX

Indicateur synthétique
PEURNEUTREAVIDITÉ
51
Neutral

Risikoanalyse

VaR (95%)-2.40%
DCA Gesundheit
86/100

Jüngste Geschichte (60 Tage)

DatumSchlusskursVolumen
2026-07-17158,17 $US1.670.048
2026-07-16159,93 $US1.665.518
2026-07-15154,88 $US1.627.771
2026-07-14150,65 $US1.480.731
2026-07-13153,83 $US1.104.010
2026-07-10151,94 $US809.250
2026-07-09150,85 $US1.385.866
2026-07-08150,56 $US2.287.600
2026-07-07156,30 $US1.757.600
2026-07-06155,54 $US1.055.626
2026-07-02158,08 $US1.659.541
2026-07-01152,90 $US1.448.099
2026-06-30151,33 $US2.057.201
2026-06-29155,19 $US2.356.843
2026-06-26155,92 $US4.618.261
2026-06-25151,38 $US1.904.207
2026-06-24147,77 $US1.553.754
2026-06-23143,92 $US2.152.091
2026-06-22140,71 $US3.382.221
2026-06-18143,98 $US2.298.226
2026-06-17141,61 $US2.049.233
2026-06-16145,16 $US941.337
2026-06-15145,52 $US1.074.972
2026-06-12146,24 $US1.604.780
2026-06-11147,35 $US1.336.825
2026-06-10147,79 $US1.413.080
2026-06-09152,04 $US2.214.855
2026-06-08149,99 $US1.925.463
2026-06-05151,16 $US1.611.864
2026-06-04149,56 $US2.241.565
2026-06-03145,61 $US1.304.633
2026-06-02144,43 $US2.085.837
2026-06-01145,33 $US2.353.996
2026-05-29147,12 $US3.658.099
2026-05-28148,41 $US2.456.040
2026-05-27147,24 $US2.878.200
2026-05-26147,75 $US3.243.481
2026-05-22147,63 $US1.004.167
2026-05-21146,25 $US1.574.560
2026-05-20146,95 $US2.057.077
2026-05-19146,95 $US3.053.565
2026-05-18142,35 $US3.773.030
2026-05-15143,47 $US4.277.310
2026-05-14144,47 $US2.319.158
2026-05-13144,18 $US3.650.067
2026-05-12147,51 $US3.465.234
2026-05-11143,15 $US3.378.688
2026-05-08149,43 $US4.019.734
2026-05-07153,26 $US5.132.482
2026-05-06144,76 $US3.399.234
2026-05-05144,17 $US2.810.660
2026-05-04146,31 $US1.925.651
2026-05-01149,31 $US1.818.077
2026-04-30149,04 $US1.943.949
2026-04-29145,31 $US2.917.648
2026-04-28149,52 $US2.094.893
2026-04-27150,22 $US2.681.313
2026-04-24152,14 $US1.729.488
2026-04-23154,85 $US2.664.370
2026-04-22155,65 $US1.957.052

Jüngste Dividenden

DatumBetrag
2026-03-10+1,05 $US
2025-12-08+1,05 $US
2025-09-08+1,04 $US
2025-06-09+1,04 $US
2025-03-10+1,04 $US
2024-12-09+1,04 $US
2024-09-09+0,95 $US
2024-06-10+0,95 $US
2024-03-07+0,95 $US
2023-12-07+0,95 $US
2023-09-07+0,91 $US
2023-06-08+0,91 $US
2023-03-09+0,91 $US
2022-12-08+0,91 $US
2022-09-08+0,87 $US
2022-06-08+0,87 $US
2022-03-09+0,85 $US
2021-12-09+0,85 $US
2021-09-08+0,81 $US
2021-06-08+0,81 $US

Verwandte Assets